According to @DowdEdward, Paul Offit told viewers he had not been invited to speak at an ACIP meeting occurring in Atlanta that day, and Dowd alleges this claim was false. Source: Edward Dowd on X (Dec 10, 2025). Verification should rely on the CDC’s ACIP official agenda and minutes, which publicly list invited speakers and topics and can confirm whether an invitation was issued. Source: CDC ACIP official publications. For trading, focus on vaccine-exposed equities including Pfizer (PFE), Moderna (MRNA), and Novavax (NVAX) for potential headline-driven volatility while awaiting any official CDC update; the post itself presents no primary documentation. Source: Company investor relations and product disclosures; CDC ACIP updates. If headlines escalate, broader risk sentiment could spill into crypto given the post-2020 rise in equity–crypto correlation. Source: International Monetary Fund analysis on crypto–stock correlation (2022).

According to @DowdEdward, former CDC Director Dr. Robert Redfield said he would like mRNA vaccine use curtailed and personally eliminated due to too many unknowns in an EpochTV American Thought Leaders interview scheduled for Dec. 9, 2025, highlighting potential headline risk for health-care and biotech equities; source: @DowdEdward; The Epoch Times. The comments pertain to mRNA COVID-19 products, including Pfizer-BioNTech’s Comirnaty (PFE, BNTX) and Moderna’s Spikevax (MRNA), which the U.S. FDA identifies as mRNA vaccines; source: U.S. Food and Drug Administration. Event-driven headlines of this type are typically monitored by options traders for potential implied-volatility repricing and gap risk in MRNA, PFE, BNTX and NVAX around the broadcast window; source: Cboe Options Institute. Because spot crypto trades continuously, cross-asset sentiment from major health-policy headlines can be reflected in BTC and ETH liquidity during off-hours, so crypto desks may track the interview’s release for any risk-on/off spillover; source: Coinbase Exchange.